the impact of moringa leaf-based innovations on hemoglobin levels among pregnant women

Background: anemia among pregnant women remains a pressing public health concern, particularly in regions with limited access to nutritious food. this study assessed the impact of supplementing moringa leaf extract in conjunction with iron (fe) tablets on hemoglobin (hb) levels during pregnancy.methods: this study used a quasi-experimental approach conducting both pre- and post-tests on participants who were given either moringa extract along with fe tablets (intervention group) or only fe tablets (control group). conducted in penyengat olak village, muaro jambi regency, indonesia from march to november 2024, the study involved 80 pregnant women who were randomly allocated into two equal groups. hemoglobin levels were assessed before and after a 14-day intervention. data were analyzed using paired and independent t-tests.results: the experimental group experienced a significant increase in mean hb levels from 11.27 g/dl to 12.12 g/dl (p<0.0001). the control group also saw an improvement (11.27 g/dl to 11.70 g/dl; p<0.0001), though to a lesser extent. the difference in post-intervention hb levels between the two groups was statistically significant (p=0.017).conclusions: the dual supplementation of moringa leaf extract and fe tablets demonstrated greater efficacy in raising hemoglobin levels among pregnant women as compared with iron tablets alone.